Paolo Banchero
26-27 Projection
PTS: league rank #14, top 20 in the league.
ORL
Young player, so the projection weights the latest season more heavily than the standard blend.
Value
+2.73
League Leader12.9
This Player8.4
League Average4.2
Ranking Trend
Lower rank is better.
Full data
| Season | Rank |
|---|---|
| 22-23 | #208 |
| 23-24 | #151 |
| 24-25 | #130 |
| 25-26 | #107 |
| 26-27 Projection | #109 |
Stat Trend
Track role, durability, and category growth by season.
Full data
| Season | PTS |
|---|---|
| 22-23 | 20 |
| 23-24 | 22.6 |
| 24-25 | 25.9 |
| 25-26 | 22.2 |
| 26-27 Projection | 23.7 |
Within-Season Trend
PTS by month across 25-26 (averages). Useful for spotting injury recovery and rookie/second-year ramps. Change the stat with the selector above.
Fantasy playoffs (final ~3 weeks)NBA playoffs (aggregate — not in averages or ranks)
Full data
| Month | PTS |
|---|---|
| Oct 2025 | 22.5 |
| Nov 2025 | 20.8 |
| Dec 2025 | 18.9 |
| Jan 2026 | 24.6 |
| Feb 2026 | 21.5 |
| Mar 2026 | 24.9 |
| Apr 2026 | 18.9 |
| Playoffs (playoffs) | 26.3 |
Fantasy playoffs run the final ~3 weeks of the season (late March into April); shown approximately at month resolution and dependent on your league's settings. ESPN and Yahoo defaults differ by about a week.
Depth Chart
Depth Chart
ORL — all five positions, best player first at each spot.
Season History
Compare season stats and fantasy ranks for draft analysis.
| SeasonNBA season | AgeAge during the season | TeamTeam | GPGames played | GSGames started | MPGMinutes per game | RankOverall fantasy rank (averages) | ValueFantasy ranking value (averages) | PTSPoints per game | REBRebounds per game | ASTAssists per game | STLSteals per game | BLKBlocks per game | 3PMThree-pointers made per game | FG%Field goal percentage | FGAField goal attempts per game | FT%Free throw percentage | FTAFree throw attempts per game | TOTurnovers per game |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-27 ProjectionModel Zero | 24 | ORL | 68 | 0 | 35 | #109 | 2.73 | 23.7 | 8.3 | 5.3 | 0.8 | 0.6 | 1.4 | 45.6% | 17.7 | 75.7% | 8.5 | 3.2 |
| 25-26 | 23 | ORL | 72 | 0 | 34.7 | #107 | 2.28 | 22.2 | 8.4 | 5.2 | 0.7 | 0.6 | 1.2 | 45.9% | 16 | 77.5% | 8.2 | 3.1 |
| 24-25 | 22 | ORL | 46 | 0 | 34.4 | #130 | 1.54 | 25.9 | 7.5 | 4.8 | 0.8 | 0.6 | 1.9 | 45.2% | 19.8 | 72.7% | 8.4 | 3 |
| 23-24 | 21 | ORL | 80 | 0 | 35 | #151 | 0.82 | 22.6 | 6.9 | 5.4 | 0.9 | 0.6 | 1.5 | 45.5% | 17.6 | 72.5% | 7 | 3.1 |
| 22-23 | 20 | ORL | 72 | 0 | 33.7 | #208 | -0.69 | 20 | 6.9 | 3.7 | 0.8 | 0.5 | 1.2 | 42.7% | 15.6 | 73.8% | 7.4 | 2.8 |